Table 1.

The signal transductivities of signal transduction pathways in Figure 2 from extracellular signals to 28 TFs in non-leukemia normal cells and acute myeloid leukemia (AML) cancer cells.

TFs	Signal transductivity
	Non-leukemia	AML
CSLs	0.0059	0.2267
P300	0.0002	0.0065
CTBPs	0.2330	0.1233
AP-2α	0.0001	0.0027
STATs	0.1551	0.9443
c-Jun	0.0017	0.0096
β-catenin	0.0160	0.0659
LEF-1	0.2295	0.0537
TCFs	0.0198	0.0096
c-Myc	0.0257	0.0016
C-Fos	0.0003	0.0000
CREBs	0.0168	0.0029
Elk-1	0.0321	0.0057
P53	0.0219	0.0013
FOXO3a	0.0050	0.0000
NF-κBs	0.0052	0.0001
HIF-1α	0.0000	0.0000
E2Fs	0.0001	0.0000
pRb	0.0003	0.0001
C/EBPα	0.0196	0.0023
AML1	0.0357	0.0134
ETO	0.0064	0.0099
PLZF	0.0011	0.0020
PU.1	0.0041	0.0072
Smad2	0.0373	0.0297
Smad3	0.4713	0.1089
Smad4	0.0150	0.1090
GLIs(Ci)	0.0803	0.0132